BICLUSTER_ID : UPREG-256
PATHOGENS /2/ : yersinia enterocolitica,aeromonas caviae
TARGETS /25/ : LCK, JUN, PLA2G2A, TNFRSF1B, AMN, SLC1A5, PIM1, IL2RA, CD86, IFNG, STAT1, JAK2, SLC22A4, BMP2, PDGFRA, IL2RG, ITGB3, CSF2RA, F3, IL1B, CASP1, ALOX15, ABP1, TNF, PTK2B
Gene SetLeading Edge Genes
NETPATH IL 2 PATHWAY UPPFKFB3, PRF1, ETS1, NMI, IFI44, IFNG, CFLAR, IFIT1, B4GALT5, SP100, LPIN2, CSF1, TNFSF10, IL10, NFIL3, IFITM3, LCP2, IL1B, CCL3, CASP1, IRF1, MYC, UPP1, AHR, GBP1, ISGF3G, TNFRSF1B, SOCS3, TRAFD1, SLC1A5, SOCS1, IL2RA, PIM1, CCL4, KLF6, CCR1, PTPRC, TRIM21, SAMHD1, SNTB1, DAXX, PBEF1, MX1
NETPATH IL 4 PATHWAY UPFGL2, AHR, JUN, ETV3, IL13RA2, ARID5B, CH25H, SOCS3, IL1RN, SAMSN1, SOCS1, IFNG, AIM1, CD86, S100A9, EGR2, MXD1, IBRDC3, CITED2, SLC22A4, BMP2, RBMS1, IL10, NFIL3, RSAD2, F3, UPP1, MYC
NCI IL2 1PATHWAYSTAT1, LCK, JAK3, SOCS3, IL2RG, STAT3, SOCS1, IFNG, IL2RA, MYC, PTK2B
NCI IL23PATHWAYSOCS3, ALOX12B, IL1B, CXCL1, JAK2, IFNG, CXCL9, TNF
NCI IL12 2PATHWAYJAK2, IL1B, CCL3, SOCS1, STAT3, IL2RA, IFNG, CCL4
NETPATH IL 6 PATHWAY UPJUN, CXCL1, PLA2G2A, LOH11CR2A, CITED2, CISH, MAP3K8, PDGFRA, NMI, SOCS3, ZFP36, SOCS1, PIM1, IRF1, PRDM1, MX1
NCI IL27PATHWAYIL1B, JAK2, STAT2, IFNG, TNF
NCI IL12 STAT4PATHWAYPRF1, JUN, CD247, STAT3, CD86, IFNG, IL2RA, IRF1
NCI IL4 2PATHWAYPARP14, JAK2, JAK3, IL13RA2, IRF4, IL10, ETS1, ITGB3, SOCS3, IL4R, CCL11, SOCS1, BCL6, ALOX15, EGR2
NETPATH IL 4 PATHWAY DOWNLITAF, TIMP1, TNFSF10, GBP2, AMN, CHI3L1, TLR3, GEM, DST, BCL6, IRF1, IL2RA, MX1, TNF
NETPATH IL 3 PATHWAY UPCSF1, CISH, CCR1, SOCS3, NFIL3, CSF2RA, IL1B, CCL3, SOCS1, PIM1, MYC, CCL4
SA MMP CYTOKINE CONNECTIONCSF1, IL1B, TNF
NETPATH IL 5 PATHWAY UPNFKBIE, CCR1, NFIL3, LCP2, SNTB1, CCL3, PIM1, ABP1, UPP1, PRDM1, EGR2, CASP4
NETPATH IL 9 PATHWAY UPSOCS3, CCL3, CITED2, PIM1, MYC
NETPATH IL 7 PATHWAY UPCXCL5, CCL3, CXCL1, IL2RA, MYC, CCL4
BIOCARTA PML PATHWAY
GRAHAM NORMAL QUIESCENT VS NORMAL DIVIDING UP
MAHAJAN RESPONSE TO IL1A UP
HAHTOLA SEZARY SYNDROM DN
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 16D UP
VARELA ZMPSTE24 TARGETS UP
ICHIBA GRAFT VERSUS HOST DISEASE D7 UP
REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS
REACTOME PEPTIDE LIGAND BINDING RECEPTORS
TENEDINI MEGAKARYOCYTE MARKERS
LINDSTEDT DENDRITIC CELL MATURATION B
KRASNOSELSKAYA ILF3 TARGETS UP
SAKAI CHRONIC HEPATITIS VS LIVER CANCER DN
LINDSTEDT DENDRITIC CELL MATURATION A
RADAEVA RESPONSE TO IFNA1 UP
LINDSTEDT DENDRITIC CELL MATURATION D
NETPATH T CELL RECEPTOR PATHWAY DOWN
WATANABE ULCERATIVE COLITIS WITH CANCER DN
BOWIE RESPONSE TO EXTRACELLULAR MATRIX
BIOCARTA NKT PATHWAY
BROWNE INTERFERON RESPONSIVE GENES
NCI IL6 7PATHWAY
WILENSKY RESPONSE TO DARAPLADIB
TONKS TARGETS OF RUNX1 RUNX1T1 FUSION ERYTHROCYTE UP
ROETH TERT TARGETS UP
ST TYPE I INTERFERON PATHWAY
HINATA NFKB TARGETS KERATINOCYTE UP
MILICIC FAMILIAL ADENOMATOUS POLYPOSIS DN
MARKEY RB1 ACUTE LOF UP
XU AKT1 TARGETS 6HR
NUYTTEN EZH2 TARGETS UP
DUTTA APOPTOSIS VIA NFKB
BIOCARTA IL22BP PATHWAY
NCI REMOVAL OF AMINOTERMINAL PROPEPTIDES FROM GAMMA CARBOXYLATED PROTEINS
POOLA INVASIVE BREAST CANCER UP
DIRMEIER LMP1 RESPONSE EARLY
DER IFN GAMMA RESPONSE UP
LIU VAV3 PROSTATE CARCINOGENESIS UP
REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES
SEITZ NEOPLASTIC TRANSFORMATION BY 8P DELETION UP
BENNETT SYSTEMIC LUPUS ERYTHEMATOSUS
DAUER STAT3 TARGETS DN
RUTELLA RESPONSE TO HGF VS CSF2RB AND IL4 UP
NAKAYAMA SOFT TISSUE TUMORS PCA1 UP
LIAN LIPA TARGETS 6M
MCLACHLAN DENTAL CARIES UP
JAATINEN HEMATOPOIETIC STEM CELL DN
FOSTER INFLAMMATORY RESPONSE LPS DN
LEE LIVER CANCER E2F1 UP
GAURNIER PSMD4 TARGETS
HELLER SILENCED BY METHYLATION UP
GRANDVAUX IFN RESPONSE NOT VIA IRF3
FARMER BREAST CANCER CLUSTER 1
OSAWA TNF TARGETS
BOWIE RESPONSE TO TAMOXIFEN
PICCALUGA ANGIOIMMUNOBLASTIC LYMPHOMA UP
ICHIBA GRAFT VERSUS HOST DISEASE 35D UP
SMID BREAST CANCER LUMINAL B DN
ZHOU INFLAMMATORY RESPONSE LPS UP
BOQUEST STEM CELL CULTURED VS FRESH DN
NOJIMA SFRP2 TARGETS DN
BROWNE HCMV INFECTION 2HR UP
CORUM REL-MAP3K8-RELA-TNIP2-PAPOLA COMPLEX
LEE LIVER CANCER MYC E2F1 UP
VERHAAK AML WITH NPM1 MUTATED UP
WAMUNYOKOLI OVARIAN CANCER GRADES 1 2 DN
GEISS RESPONSE TO DSRNA UP
GRAHAM CML DIVIDING VS NORMAL QUIESCENT DN
SATO SILENCED BY METHYLATION IN PANCREATIC CANCER 1
CORUM TNF-ALPHA/NF-KAPPA B SIGNALING COMPLEX RPL6 RPL30 RPS13 CHUK DDX3X NFKB2 NFKBIB REL IKBKG NFKB1 MAP3K8 RELB GLG1 NFKBIA RELA TNIP2 GTF2I
ST TUMOR NECROSIS FACTOR PATHWAYNFKBIE, CFLAR
GRANDVAUX IRF3 TARGETS UP
ZHU CMV ALL UP
KEGG TOLL LIKE RECEPTOR SIGNALING PATHWAY
HUANG DASATINIB RESISTANCE UP
KEGG CYTOKINE CYTOKINE RECEPTOR INTERACTION
NCI TCRCALCIUMPATHWAY
CHEN LVAD SUPPORT OF FAILING HEART DN
ZHANG INTERFERON RESPONSE
SATO SILENCED EPIGENETICALLY IN PANCREATIC CANCER
CHANG IMMORTALIZED BY HPV31 DN
RUIZ TNC TARGETS UP
AUJLA IL22 AND IL17A SIGNALING
SCHUHMACHER MYC TARGETS DN
KANG GIST WITH PDGFRA UP
DORN ADENOVIRUS INFECTION 48HR UP
WALLACE PROSTATE CANCER RACE UP
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 10D UP
KINSEY TARGETS OF EWSR1 FLII FUSION DN
NETPATH IL 7 PATHWAY
TAKADA GASTRIC CANCER COPY NUMBER DN
KIM LRRC3B TARGETS
HORIUCHI WTAP TARGETS UP
WIELAND UP BY HBV INFECTION
ST INTERFERON GAMMA PATHWAY
RUTELLA RESPONSE TO CSF2RB AND IL4 DN
UROSEVIC RESPONSE TO IMIQUIMOD
CHIARADONNA NEOPLASTIC TRANSFORMATION KRAS CDC25 DN
DORN ADENOVIRUS INFECTION 32HR UP
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 3D UP
KEGG JAK STAT SIGNALING PATHWAY
GARGALOVIC RESPONSE TO OXIDIZED PHOSPHOLIPIDS GREY DN
FULCHER INFLAMMATORY RESPONSE LECTIN VS LPS DN
TURASHVILI BREAST DUCTAL CARCINOMA VS DUCTAL NORMAL DN
TSAI DNAJB4 TARGETS UP
DER IFN BETA RESPONSE UP
DIAZ CHRONIC MEYLOGENOUS LEUKEMIA DN
BASSO CD40 SIGNALING UP
NETPATH B CELL RECEPTOR PATHWAY DOWN
SOUCEK MYC TARGETS
BIOCARTA BLYMPHOCYTE PATHWAY
BIOCARTA DC PATHWAY
BOYLAN MULTIPLE MYELOMA C D DN
MAHADEVAN RESPONSE TO MP470 UP
ZHAN MULTIPLE MYELOMA LB DN
SMID BREAST CANCER NORMAL LIKE UP
KEGG AUTOIMMUNE THYROID DISEASE
KEGG RIG I LIKE RECEPTOR SIGNALING PATHWAY
SHAFFER IRF4 MULTIPLE MYELOMA PROGRAM
SANA RESPONSE TO IFNG UP
AMUNDSON GAMMA RADIATION RESISTANCE
LIANG SILENCED BY METHYLATION 2
DAUER STAT3 TARGETS UP
KEGG LEISHMANIA INFECTION
DER IFN ALPHA RESPONSE UP
RUTELLA RESPONSE TO HGF DN
BOYLAN MULTIPLE MYELOMA PCA1 UP
EINAV INTERFERON SIGNATURE IN CANCER
NCI CD40 PATHWAY
MCLACHLAN DENTAL CARIES DN
KEGG ALLOGRAFT REJECTION
SEKI INFLAMMATORY RESPONSE LPS UP
ZHANG RESPONSE TO IKK INHIBITOR AND TNF UP
ZHU CMV 8 HR UP
SANA TNF SIGNALING UP
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 8D UP
MOSERLE IFNA RESPONSE
SCHUETZ BREAST CANCER DUCTAL INVASIVE UP
FOSTER INFLAMMATORY RESPONSE LPS UP
BIOCARTA ASBCELL PATHWAY
XU HGF TARGETS INDUCED BY AKT1 6HR
RODWELL AGING KIDNEY UP
ODONNELL TARGETS OF MYC AND TFRC UP
CASTELLANO NRAS TARGETS UP
REACTOME P75NTR SIGNALS VIA NFKB
LIAN LIPA TARGETS 3M
KEGG CHEMOKINE SIGNALING PATHWAY
KEGG CYTOSOLIC DNA SENSING PATHWAY
BIOCARTA GRANULOCYTES PATHWAY
JISON SICKLE CELL DISEASE UP
CORUM 55S RIBOSOME MITOCHONDRIALMRPL55, MRPL9, MRPS18A, MRPL54, MRPS33, MRPL3, MRPL49, MRPL12, MRPS22, MRPS23, MRPS26, MRPS18B, MRPL34, MRPL47, MRPS7, MRPL41, MRPS12, MRPS16, MRPL35, MRPS11, MRPL40, MRPL15, MRPL36, MRPL18, MRPL1, MRPS2, MRPS17, MRPL50, MRPS24, MRPL43, MRPS31, MRPL53, MRPL21, MRPS35
CROONQUIST NRAS SIGNALING UP
HESS TARGETS OF HOXA9 AND MEIS1 DN
GRAHAM CML QUIESCENT VS NORMAL DIVIDING UP
ZHAN MULTIPLE MYELOMA HP UP
LU IL4 SIGNALING
BERTUCCI MEDULLARY VS DUCTAL BREAST CANCER UP
HOSHIDA LIVER CANCER LATE RECURRENCE UP
Color legend
q-value10.20.050.010.0010.0001
Color
TABLE OF Q-VALUES
yersinia enterocolitica wap bcaeromonas caviaGeneSet Name
0.00010 0.07215NETPATH_IL_2_PATHWAY_UP
0.00017 0.03395NETPATH_IL_4_PATHWAY_UP
0.03197 0.03816NCI_IL2_1PATHWAY
0.00001 0.00704NCI_IL23PATHWAY
0.00156 0.00545NCI_IL12_2PATHWAY
0.00000 0.10211NETPATH_IL_6_PATHWAY_UP
0.00720 0.00317NCI_IL27PATHWAY
0.01624 0.14161NCI_IL12_STAT4PATHWAY
0.02322 0.00285NCI_IL4_2PATHWAY
0.00024 0.01190NETPATH_IL_4_PATHWAY_DOWN
0.00000 0.00216NETPATH_IL_3_PATHWAY_UP
0.00860 0.02492SA_MMP_CYTOKINE_CONNECTION
0.00001 0.07327NETPATH_IL_5_PATHWAY_UP
0.00001 0.07320NETPATH_IL_9_PATHWAY_UP
0.00052 0.16616NETPATH_IL_7_PATHWAY_UP
0.05475 0.12171BIOCARTA_PML_PATHWAY
0.00000 0.01924GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP
0.00000 0.16652MAHAJAN_RESPONSE_TO_IL1A_UP
0.11747 0.00126HAHTOLA_SEZARY_SYNDROM_DN
0.00282 0.00143TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP
0.00120 0.03175VARELA_ZMPSTE24_TARGETS_UP
0.00000 0.00000ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP
0.06841 0.19868REACTOME_GAMMA_CARBOXYLATION_TRANSPORT_AND_AMINO_TERMINAL_CLEAVAGE_OF_PROTEINS
0.00741 0.13954REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS
0.07725 0.07889TENEDINI_MEGAKARYOCYTE_MARKERS
0.00004 0.00053LINDSTEDT_DENDRITIC_CELL_MATURATION_B
0.02335 0.00214KRASNOSELSKAYA_ILF3_TARGETS_UP
0.14424 0.05537SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN
0.00000 0.00124LINDSTEDT_DENDRITIC_CELL_MATURATION_A
0.00379 0.00000RADAEVA_RESPONSE_TO_IFNA1_UP
0.00297 0.15398LINDSTEDT_DENDRITIC_CELL_MATURATION_D
0.10216 0.16575NETPATH_T_CELL_RECEPTOR_PATHWAY_DOWN
0.01513 0.01527WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_DN
0.02677 0.00058BOWIE_RESPONSE_TO_EXTRACELLULAR_MATRIX
0.00470 0.18798BIOCARTA_NKT_PATHWAY
0.00000 0.00000BROWNE_INTERFERON_RESPONSIVE_GENES
0.08946 0.07318NCI_IL6_7PATHWAY
0.03303 0.00819WILENSKY_RESPONSE_TO_DARAPLADIB
0.00012 0.16527TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP
0.03831 0.00363ROETH_TERT_TARGETS_UP
0.17894 0.09960ST_TYPE_I_INTERFERON_PATHWAY
0.00000 0.06206HINATA_NFKB_TARGETS_KERATINOCYTE_UP
0.18149 0.15437MILICIC_FAMILIAL_ADENOMATOUS_POLYPOSIS_DN
0.00001 0.00000MARKEY_RB1_ACUTE_LOF_UP
0.00751 0.01113XU_AKT1_TARGETS_6HR
0.00008 0.07444NUYTTEN_EZH2_TARGETS_UP
0.00003 0.05340DUTTA_APOPTOSIS_VIA_NFKB
0.04920 0.00050BIOCARTA_IL22BP_PATHWAY
0.13733 0.19878NCI_REMOVAL_OF_AMINOTERMINAL_PROPEPTIDES_FROM_GAMMA_CARBOXYLATED_PROTEINS
0.00162 0.00390POOLA_INVASIVE_BREAST_CANCER_UP
0.00000 0.00564DIRMEIER_LMP1_RESPONSE_EARLY
0.00850 0.00005DER_IFN_GAMMA_RESPONSE_UP
0.11363 0.00001LIU_VAV3_PROSTATE_CARCINOGENESIS_UP
0.00000 0.00008REACTOME_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES
0.00000 0.00003SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_UP
0.00073 0.00041BENNETT_SYSTEMIC_LUPUS_ERYTHEMATOSUS
0.00458 0.00000DAUER_STAT3_TARGETS_DN
0.00121 0.11676RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP
0.10223 0.00001NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP
0.00074 0.01871LIAN_LIPA_TARGETS_6M
0.00000 0.00003MCLACHLAN_DENTAL_CARIES_UP
0.00069 0.01353JAATINEN_HEMATOPOIETIC_STEM_CELL_DN
0.00000 0.00001FOSTER_INFLAMMATORY_RESPONSE_LPS_DN
0.00205 0.01675LEE_LIVER_CANCER_E2F1_UP
0.00000 0.00001GAURNIER_PSMD4_TARGETS
0.00040 0.00206HELLER_SILENCED_BY_METHYLATION_UP
0.00368 0.00003GRANDVAUX_IFN_RESPONSE_NOT_VIA_IRF3
0.01810 0.00001FARMER_BREAST_CANCER_CLUSTER_1
0.05837 0.12830OSAWA_TNF_TARGETS
0.00632 0.00004BOWIE_RESPONSE_TO_TAMOXIFEN
0.00410 0.04189PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP
0.00008 0.00000ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP
0.00824 0.08643SMID_BREAST_CANCER_LUMINAL_B_DN
0.00000 0.01590ZHOU_INFLAMMATORY_RESPONSE_LPS_UP
0.14177 0.16593BOQUEST_STEM_CELL_CULTURED_VS_FRESH_DN
0.00893 0.00332NOJIMA_SFRP2_TARGETS_DN
0.02213 0.05963BROWNE_HCMV_INFECTION_2HR_UP
0.17454 0.01112CORUM_REL-MAP3K8-RELA-TNIP2-PAPOLA_COMPLEX
0.07080 0.01790LEE_LIVER_CANCER_MYC_E2F1_UP
0.00000 0.08932VERHAAK_AML_WITH_NPM1_MUTATED_UP
0.14246 0.07720WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_DN
0.00000 0.00364GEISS_RESPONSE_TO_DSRNA_UP
0.00011 0.00399GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN
0.02956 0.08380SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1
0.17372 0.14885CORUM_TNF-ALPHA/NF-KAPPA_B_SIGNALING_COMPLEX_RPL6_RPL30_RPS13_CHUK_DDX3X_NFKB2_NFKBIB_REL_IKBKG_NFKB1_MAP3K8_RELB_GLG1_NFKBIA_RELA_TNIP2__GTF2I
0.02172 0.11624ST_TUMOR_NECROSIS_FACTOR_PATHWAY
0.00217 0.06268GRANDVAUX_IRF3_TARGETS_UP
0.00018 0.14609ZHU_CMV_ALL_UP
0.00177 0.00443KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY
0.00025 0.15881HUANG_DASATINIB_RESISTANCE_UP
0.00001 0.01697KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION
0.05118 0.16624NCI_TCRCALCIUMPATHWAY
0.05654 0.10531CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN
0.00114 0.00003ZHANG_INTERFERON_RESPONSE
0.08470 0.05653SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER
0.07816 0.03023CHANG_IMMORTALIZED_BY_HPV31_DN
0.01684 0.12368RUIZ_TNC_TARGETS_UP
0.01777 0.01459AUJLA_IL22_AND_IL17A_SIGNALING
0.07151 0.11083SCHUHMACHER_MYC_TARGETS_DN
0.07698 0.05568KANG_GIST_WITH_PDGFRA_UP
0.04720 0.16772DORN_ADENOVIRUS_INFECTION_48HR_UP
0.00000 0.00000WALLACE_PROSTATE_CANCER_RACE_UP
0.00001 0.00001TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP
0.01070 0.12731KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN
0.05867 0.01572NETPATH_IL_7_PATHWAY
0.08940 0.11637TAKADA_GASTRIC_CANCER_COPY_NUMBER_DN
0.00014 0.00000KIM_LRRC3B_TARGETS
0.00023 0.12653HORIUCHI_WTAP_TARGETS_UP
0.01379 0.00000WIELAND_UP_BY_HBV_INFECTION
0.10742 0.13280ST_INTERFERON_GAMMA_PATHWAY
0.00040 0.02718RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN
0.00537 0.00001UROSEVIC_RESPONSE_TO_IMIQUIMOD
0.00124 0.00603CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN
0.09531 0.15440DORN_ADENOVIRUS_INFECTION_32HR_UP
0.00000 0.00000TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP
0.00277 0.00316KEGG_JAK_STAT_SIGNALING_PATHWAY
0.07894 0.16621GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_DN
0.00000 0.00001FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN
0.17539 0.13231TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN
0.16954 0.01036TSAI_DNAJB4_TARGETS_UP
0.00563 0.00003DER_IFN_BETA_RESPONSE_UP
0.02834 0.09215DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN
0.00000 0.00110BASSO_CD40_SIGNALING_UP
0.14141 0.15420NETPATH_B_CELL_RECEPTOR_PATHWAY_DOWN
0.00001 0.00169SOUCEK_MYC_TARGETS
0.07898 0.04205BIOCARTA_BLYMPHOCYTE_PATHWAY
0.07276 0.01876BIOCARTA_DC_PATHWAY
0.00901 0.00178BOYLAN_MULTIPLE_MYELOMA_C_D_DN
0.00006 0.00240MAHADEVAN_RESPONSE_TO_MP470_UP
0.00337 0.00000ZHAN_MULTIPLE_MYELOMA_LB_DN
0.11477 0.00209SMID_BREAST_CANCER_NORMAL_LIKE_UP
0.17971 0.04468KEGG_AUTOIMMUNE_THYROID_DISEASE
0.03958 0.10841KEGG_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY
0.00219 0.14256SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM
0.00025 0.00000SANA_RESPONSE_TO_IFNG_UP
0.17695 0.00395AMUNDSON_GAMMA_RADIATION_RESISTANCE
0.00007 0.00001LIANG_SILENCED_BY_METHYLATION_2
0.06147 0.05120DAUER_STAT3_TARGETS_UP
0.00695 0.05933KEGG_LEISHMANIA_INFECTION
0.01898 0.00000DER_IFN_ALPHA_RESPONSE_UP
0.01776 0.04351RUTELLA_RESPONSE_TO_HGF_DN
0.05131 0.00286BOYLAN_MULTIPLE_MYELOMA_PCA1_UP
0.01324 0.00000EINAV_INTERFERON_SIGNATURE_IN_CANCER
0.03530 0.06428NCI_CD40_PATHWAY
0.00001 0.00003MCLACHLAN_DENTAL_CARIES_DN
0.00070 0.01652KEGG_ALLOGRAFT_REJECTION
0.00000 0.00002SEKI_INFLAMMATORY_RESPONSE_LPS_UP
0.00000 0.00001ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP
0.00004 0.00058ZHU_CMV_8_HR_UP
0.00000 0.00000SANA_TNF_SIGNALING_UP
0.00001 0.00109TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP
0.00001 0.00000MOSERLE_IFNA_RESPONSE
0.00001 0.10206SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP
0.00000 0.01920FOSTER_INFLAMMATORY_RESPONSE_LPS_UP
0.02830 0.04179BIOCARTA_ASBCELL_PATHWAY
0.00321 0.15750XU_HGF_TARGETS_INDUCED_BY_AKT1_6HR
0.14309 0.00002RODWELL_AGING_KIDNEY_UP
0.03834 0.13045ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP
0.00048 0.02086CASTELLANO_NRAS_TARGETS_UP
0.15860 0.15842REACTOME_P75NTR_SIGNALS_VIA_NFKB
0.00070 0.04935LIAN_LIPA_TARGETS_3M
0.00276 0.01801KEGG_CHEMOKINE_SIGNALING_PATHWAY
0.01094 0.00700KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY
0.00514 0.04491BIOCARTA_GRANULOCYTES_PATHWAY
0.00072 0.00632JISON_SICKLE_CELL_DISEASE_UP
0.00000 0.00000CORUM_55S_RIBOSOME_MITOCHONDRIAL
0.18291 0.05948CROONQUIST_NRAS_SIGNALING_UP
0.00000 0.01035HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN
0.00000 0.09323GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP
0.08680 0.06325ZHAN_MULTIPLE_MYELOMA_HP_UP
0.00006 0.01920LU_IL4_SIGNALING
0.07837 0.00108BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP
0.03007 0.09619HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_UP